Sidebar is Loading...
Loading...
Brands
Resources
YSTV
ADVERTISEMENT
Loading...
Brands
Resources
YSTV
Transforming the lives of patients with life-limiting diseases of the nervous system.
Engrail Therapeutics is a clinical-stage pharmaceutical company founded in 2019 with the aspiration of becoming a leader in neuroscience. We are committed to rapidly advancing our innovative, precision-targeted therapeutics.
Legal Name
:
Engrail Therapeutics, Inc.
Headquarters
:
San Diego, California, United States of America
Business Model
:
Founding Date
:
2019
No. of Employees
:
21 to 40
Core Team
:
1.
Vikram Sudarsan
President and CEO
2.
Stephen Cunningham
Co-Founder and Chief Development Officer
Total Funding
$221.0M
Investors
:
1.
Nan Fung Life Sciences
2.
Forbion Capital Partners
3.
F-Prime Capital
4.
Norwest Venture Partners
See More
Chemicea Pharmaceuticals Pvt. Ltd. is an India-based pharmaceutical company specializing in the synthesis and supply of high-purity impurity reference standards, including process impurities, degradation products, and nitrosamines. Founded in 2016 and headquartered in Navi Mumbai, the company supports global pharmaceutical and research organizations with products and services for drug development, quality control, and regulatory compliance.
Frequently Asked Questions
Chemicea Pharmaceuticals Pvt. Ltd. is an India-based pharmaceutical company specializing in the synthesis and supply of high-purity impurity reference standards, including process impurities, degradation products, and nitrosamines. Founded in 2016 and headquartered in Navi Mumbai, the company supports global pharmaceutical and research organizations with products and services for drug development, quality control, and regulatory compliance.
